Profile for Morocco Patent: 32719
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Morocco Patent: 32719
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Dec 21, 2029 | Novartis | TEKAMLO | aliskiren hemifumarate; amlodipine besylate |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
